Upregulating miRNA-27a suppresses SYK translation, reducing NF-κB activity to inhibit NLRP3/Caspase-1/IL-1β/GSDMD-N, alleviating pyroptosis/neuroinflammation and depression. Here, NFKB1 is linked to depressive symptom measurement.